Nandrolone
- Generic Name
- Nandrolone
- Drug Type
- Small Molecule
- Chemical Formula
- C18H26O2
- CAS Number
- 434-22-0
- Unique Ingredient Identifier
- 6PG9VR430D
- Background
Nandrolone, also known as 19-nortestosterone or 19-norandrostenolone, is a synthetic anabolic-androgenic steroid (AAS) derived from testosterone.
- Associated Conditions
- Osteoporosis (Senile), Osteoporosis caused by Glucocorticoid Treatment
Anabolic Steroids for Nutritional Rehabilitation of Critically Ill Patients
Phase 2
Terminated
- Conditions
- MalnutritionCritical Illness
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-10-20
- Last Posted Date
- 2011-01-05
- Lead Sponsor
- Lawson Health Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT00242463
- Locations
- 🇨🇦
London Health Sciences Centre-UC, London, Ontario, Canada
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders
Phase 3
Completed
- Conditions
- Hematologic DiseasesPancytopeniaAnemia, AplasticBlood Disease
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath